NXGL
NEXGEL, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$0.45-5.49%
Price as of Jul 20, 2026
NXGL financials
NEXGEL, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $11.4M | $8.7M | $4.1M | $2.0M |
| Cost of revenue | $6.9M | $5.9M | $3.7M | $1.8M |
| Gross profit | $4.5M | $2.7M | $374.0K | $256.0K |
| Operating expenses | $7.9M | $6.3M | $3.9M | $3.6M |
| Operating income | -$3.4M | -$3.6M | -$3.5M | -$3.3M |
| Net income | -$3.0M | -$3.3M | -$3.2M | -$4.7M |
| EBITDA | -$2.1M | -$2.9M | -$2.7M | -$3.1M |
| Basic EPS | $-0.38 | $-0.50 | $-0.56 | $-0.85 |
| Diluted EPS | $-0.38 | $-0.50 | $-0.56 | $-0.85 |
| Balance sheet | ||||
| Cash & equivalents | $317.0K | $1.8M | $2.7M | $1.1M |
| Total assets | $10.5M | $11.0M | $10.0M | $10.4M |
| Total liabilities | $5.6M | $4.9M | $4.8M | $2.7M |
| Stockholders’ equity | $4.5M | $5.8M | $4.7M | $7.6M |
| Total debt | $3.1M | $2.8M | $2.8M | $2.1M |
| Net debt | $2.8M | $1.0M | $98.0K | $982.0K |
| Cash flow | ||||
| Operating cash flow | -$1.3M | -$3.9M | -$3.2M | -$3.0M |
| Capital expenditure | -$68.0K | -$443.0K | -$696.0K | -$96.0K |
| Free cash flow | -$1.4M | -$4.3M | -$3.9M | -$3.1M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |